Target intelligence / Profile preview

Antimony (Sb) (Sb)

Target
Sb
01

Overview

Antimony is a chemical element (symbol Sb, atomic number 51) and a metalloid that has been used medicinally for centuries, primarily as a treatment for leishmaniasis [8, 13]. In modern pharmacology, it is administered as pentavalent antimonial prodrugs, such as sodium stibogluconate and meglumine antimoniate, which are reduced to the active trivalent form (SbIII) within the target parasite [2, 10]. The primary mechanism of action involves the inhibition of trypanothione reductase, an essential enzyme for the parasite's redox balance, leading to oxidative stress and cell death [1, 8]. Additionally, antimony interferes with energy metabolism by inhibiting phosphofructokinase and may impair DNA replication through the inhibition of topoisomerase I [2, 5]. Beyond its antiparasitic role, antimony compounds are being investigated for their ability to inhibit human protein tyrosine phosphatases like SHP-1, which could have applications in cancer immunotherapy [9, 14]. Despite its efficacy, the therapeutic use of antimony is constrained by significant systemic toxicities, including cardiotoxicity and pancreatitis, and the emergence of widespread drug resistance in endemic regions [8, 16].

Other names
StibiumAntimony(III)Antimony(V)Trivalent antimonyPentavalent antimony
02

Biological functions

Other
03

Disease associations

InfectionCancer
04

Interacting drugs

Dimercaprol}
05

Biomarkers

Blood antimony concentrationElectrocardiogram (QT interval monitoring)Serum amylase and lipase levelsLiver function tests (ALT/AST)

Beyond the preview

Go deeper on Antimony (Sb) (Sb).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antimony (Sb) (Sb).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call